InvestorsHub Logo
Followers 110
Posts 5606
Boards Moderated 0
Alias Born 09/28/2011

Re: dr_lowenstein post# 177535

Wednesday, 01/06/2016 9:30:41 PM

Wednesday, January 06, 2016 9:30:41 PM

Post# of 410069
Elite's phase III trials successfully tested the efficacy of its ELI-200 formulation. Purdue was avoiding a meeting with the FDA.

Cheers!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News